anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

226,261-226,320 of 319,975

filter-aware
22
The chart uses a waterfall structure to bridge gross debt to allocated net debt for Lionsgate Studios.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank Beat · FinancialsLoop · Why Now1 hit
23
Lionsgate | SPAC Presentation Deck | 30 slidesLionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
24
This is a standard financial disclosure slide explaining the methodology behind non-GAAP metrics used in the presentation.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
25
Includes footnotes explaining the basis of estimates and definitions.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
26
Includes detailed footnotes explaining NRE (Not Reasonably Estimated) items.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
27
The slide uses 'NRE' (Not Reasonably Estimable) for line items, with a single quantitative data point of $60.0 million for the final Adjusted OIBDA.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
28
Includes Safe Harbor Statement and specific footnotes regarding intercompany debt and paydown.Lionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
29
Lionsgate | SPAC Presentation Deck | 30 slidesLionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
30
Lionsgate | SPAC Presentation Deck | 30 slidesLionsgate | SPAC Presentation Deck | 30 slides · Lionsgate
Conference presentation Investment bank 1 hit
01
Slide 1
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Attention1 hit
02
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a high-end aesthetic typical of luxury brand presentations, likely for LVMH or a related entity.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a mix of circular imagery and text blocks to highlight key performance indicators and qualitative business updates.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Attention1 hit
05
The slide is divided into two main sections: 'Focusing on key areas of action' (social) and 'Putting the environment at the heart of the creative process' (environmental).LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a semi-transparent white overlay box to highlight the section title over a fashion show photograph.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a split-screen layout to contrast two business segments.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
08
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
09
Slide 9 from LVMH 2023 Annual Results presentation.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
10
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
11
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
12
The slide uses a high-quality photograph of a Tiffany & Co. store interior as the background.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
13
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
14
The slide serves as a section divider or speaker introduction.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
15
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The chart illustrates the bridge between 2022 and 2023 revenue figures.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
17
LVMH | Results Presentation Deck | 31 slidesLVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
18
The chart uses a grouped bar structure for each region, showing Q1-Q4 and the full-year 2023 average.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The table highlights the performance of various business segments, with Wines & Spirits being the only one showing a decline.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
20
The chart displays quarterly performance (Q1-Q4) and full-year 2023 for six business segments.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
21
The table includes a row for operating margin percentage and a row for 'Other activities & eliminations'.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
22
The table shows revenue, margins, expenses, and profit metrics with year-over-year percentage changes.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Satisfaction1 hit
23
The chart illustrates a bridge from 21,055 M€ in 2022 to 22,802 M€ in 2023.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
24
The table shows a breakdown of financial costs and adjustments, with a total net financial result change of -47 million euros.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
25
The slide uses a stacked bar chart to represent the balance sheet structure.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
26
The table breaks down cash flow from operations, net cash from operating activities, and operating free cash flow.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
27
The chart combines a bar chart for debt (in millions of euros) and a line chart for the gearing percentage.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
28
The 2023 dividend is subject to approval at the Annual General Meeting.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations Beat · Action1 hit
29
The slide features a high-fashion photograph of a woman with a Louis Vuitton handbag, likely used as a stylistic transition or section break.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
30
The slide presents two distinct tables stacked vertically, comparing year-over-year performance.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
31
Includes a disclaimer regarding rounding discrepancies in totals.LVMH | Results Presentation Deck | 31 slides · LVMH
Conference presentation Investor relations 1 hit
01
Slide 1
The background image appears to be a microscopic view of chromosomes or cellular structures, reinforcing the 'telomere' focus.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
02
MAIA Biotechnology | Investor Presentation Deck | 31 slidesMAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
03
The slide outlines the status of THIO-101, 102, and 103, highlighting FDA designations and clinical trial progress.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · The Ask1 hit
04
The slide uses a custom timeline/pipeline layout to show drug development stages.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
05
MAIA Biotechnology | Investor Presentation Deck | 31 slidesMAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
06
The slide uses a three-column layout with circular callouts to emphasize demographic trends and disease prevalence.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
07
This is a transition or thesis slide emphasizing competitive differentiation.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide illustrates a sequential therapeutic approach: THIO treatment followed by CPI therapy.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
09
Slide highlights a strategic partnership/traction milestone.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
10
The chart demonstrates tumor volume reduction over time, highlighting the efficacy of the THIO + Atezo combination.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
11
The slide outlines a multi-part clinical trial process from Part A (Safety) through Part B (Efficacy/Dose Selection) to a planned Expansion phase.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
12
The table compares a standard of care (Cyramza), a regulatory benchmark, and the company's own drug candidate (THIO-101).MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
13
Data cut of ongoing study THIO-101 as of 13Nov2023.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
14
The slide uses a specific medical study to justify a change in clinical trial endpoint strategy.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
15
Data cut as of 13Nov2023.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
16
The chart tracks individual patient timelines, including disease progression, partial responses, and study outcomes.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
17
The slide outlines a multi-part clinical trial design (basket/umbrella) for a biotech drug candidate.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
18
The slide presents two line charts showing tumor volume reduction over time, highlighting 100% complete response (CR) and resistance to tumor rechallenge.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
19
The slide shows two line charts comparing tumor volume reduction across different treatment regimens in mouse models.MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
20
The chart shows tumor volume over time, with the THIO group reaching 100% complete response (CR).MAIA Biotechnology | Investor Presentation Deck | 31 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit